Clinical efficacy of single-port thoracoscopic surgery for thymoma

Abstract

Objective To investigate the clinical efficacy and safety of single-port thoracoscopic surgery for thymoma. Methods 22 patients with thymoma were randomly divided into two groups, 10 patients in single-port video-assisted thoracoscopic surgery group (VATS group) and 12 patients in thoracotomy group. Perioperative indicators such as length of incision, intraoperative blood loss, operation time, postoperative chest volume, and extubated time of both groups were observed. The postoperative inflammation index, pain score, and total incidence of complications in both groups were compared. Results The length of surgical incision, extubated time in the VATS group were much shorter and the intraoperative blood loss, postoperative thoracic drainage were much less than those in the thoracotomy group (P 0.05) . The white blood cell count and CRP level in the VATS group were much lower than those in the thoracotomy group both on Day 1 and Day 5 after operation (P 0.05). Conclusions The short-term clinical efficacy of single-port VATS thymoma combined with anterior mediastinal fat culling is just a safe and feasible method for the treatment of thymoma as thoracotomy. Meanwhile, it has the advantages of smaller trauma, lighter pain, less complications and rapid recovery. Key words: video-assisted thoracoscopic surgery, Single-port; Thymoma; Clinical efficacy